Bold Demand-Side Action Required In Face Of Methamphetamine Surge
New Zealand must invest in bold action to reduce demand for methamphetamine in the face of a recent surge in consumption, the NZ Drug Foundation says.
Wastewater testing data shows that methamphetamine consumption has doubled in the last year, with acute social and health impacts being reported in areas with the highest rates of use.
Drug Foundation Executive Director Sarah Helm says being overly reliant on supply-side interventions like seizures and drug busts won't shift the dial and that seriously addressing demand is the only way to solve the issue.
'We've seen a doubling of methamphetamine use in spite of record-breaking seizures by Police and Customs,' she says.
'If we don't address demand and addiction, supply-side measures are short-lived, because as one supply source is removed another supplier steps in to meet the demand. We need to be bold and get serious about reducing demand, preventing harm and making addiction treatment much more accessible to people.'
Helm says there are a range of proven and emerging interventions that the Foundation and the sector are urging the government to adopt, including:
A rapid escalation of addiction treatment, including investment in accessible community-based, peer-led groups
Revamping and expanding proven health-based responses like Te Ara Oranga
A campaign that reduces stigma and encourages people to have conversations about their use with loved ones and to access help
Ramping up prevention by tackling unmet health needs by:
--offering better support and treatment for people who use methamphetamine and have ADHD (one Australian study showed 45% of people who use illicit stimulants regularly screened positive for ADHD)
--investigating medication-assisted treatment options for people with methamphetamine dependence
Increasing harm reduction service availability, for example access to sterile injecting equipment to prevent communicable disease impacts
More kaupapa Māori-driven health responses
Helm says that she's optimistic about progress, especially as Mental Health Minister Matt Doocey has experience in the addictions sector and understands the issues.
'We've had many years of inaction on drug issues, but we have had very positive engagement with the Minister, including at a summit with almost 200 people from across the sector who offered up advice on how to tackle the serious challenges we are facing, so we are hopeful for progress,' she says.
Helm also acknowledges that demand reduction measures on their own risk being band aids without addressing the underlying social and economic drivers of methamphetamine use.
'Ultimately, this issue is bigger than any one sector or government portfolio and there are no quick fixes, but that doesn't need we shouldn't start doing what we know will work.'
Methamphetamine consumption (mg/day/1000 population) 2019- 2024
Using Scoop for work?
Scoop is free for personal use, but you'll need a licence for work use. This is part of our Ethical Paywall and how we fund Scoop. Join today with plans starting from less than $3 per week, plus gain access to exclusive Pro features.
Join Pro Individual Find out more
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Scoop
14 hours ago
- Scoop
Integration Of Māori Healing And Mainstream Healthcare Delivers Social Impact
Te Arateatea Trust is successfully bridging traditional Māori healing practices with mainstream healthcare, offering an inclusive, holistic health service, particularly for expectant and new mothers. The organisation operates Te Ara Teatea, a Whare Hauora (health clinic) established in response to community needs, with an additional focus on training practitioners in rongoā Māori, the traditional Māori system of healing. Rongoā Māori is a holistic approach that interconnects physical, mental, and spiritual wellbeing, along with rongoā rākau (herbal remedies), mirimiri and romiromi (physical therapies), and spiritual healing practices. Trust Founder Ruatau Perez [Ngāi Tuhoe, Ngāpuhi] says this integration offers a more complete approach to wellbeing, addressing the whole person rather than just physical symptoms. "It's quite empowering seeing how the two modalities are slowly coming together - the traditional and the mainstream way of health. When you support the spiritual health, the mental and the psychological health as well as the physical, and understand the interconnected relationship between people and the natural environment, it's really empowering." Based in Woolston, Ōtautahi, the organisation provides services ranging from injury rehabilitation to Corrections work, and support for fertility and pregnancy, including vulnerable young women who might not otherwise engage in ante- and post-natal care. A key component is their Oriori mentoring programme, which supports young mothers and their pēpi while training community members and staff in traditional practices. Danielle O'Halloran-Thyne, who received mentoring through the Oriori programme to specialise as a hapūtanga (pregnancy) practitioner in rongoā Māori, says the programme creates a safe learning environment for practitioners. "Our services aim to provide one of the alternatives that complements other forms of healthcare that can really uplift the mana of the wahine and allow them to feel that it is a time of empowerment for them, not just a hard time. The resurgence of rongoā Māori and the acknowledgement that yes it does assist, that's a game changer for access to rongoā Māori, so that people can feel it's normal. What Te Arateatea is holding for us as practitioners is a really safe space to learn and grow and be part of that resurgence." Juliette, who has been with the hapūtanga (pregnancy) programme for three years, says the clinic offers a warm, welcoming healing environment. "They helped me through the pregnancy side of things - the joys that come up through pregnancy but also the emotional side. It has helped a lot of us accept what happened because it is out of your control and sometimes it's hard to acknowledge those things. It has helped me to see the journey in a positive light. It's such a good, calm space. I recommend it to everyone." This integration of traditional practices with modern healthcare addresses various needs identified in the Waitangi Tribunal Hauora report, including isolation, lack of family support, and poverty. With funding from Rātā and other partners, these services are available at no cost to mothers who may not be able to access support during pregnancy and after birth, removing financial barriers. "The funding from Rātā has really been incredible in helping us to really get it out into the community so that people can access these services that they may not otherwise have been able to access," says Ruatau. "It's great to see the benefits of these two approaches working together to provide better care for our whānau." Te Arateatea Trust is supported through Rātā Foundation's Strategic Health Pou (funding priority), which aims to remove barriers to mental health support and enable access to diverse support options, including rongoā and innovative locally based solutions. Rātā Chief Executive Leighton Evans says the key focus of this funding area is to ensure people in need get the right support when they need it. "We want individuals, families and whānau to thrive so they can participate positively in the community. A key part of this is being able to access support and services in a way that is comfortable and familiar, and aligned with community, culture and identity. "Providing support to organisations such as Te Arateatea Trust enables them to focus on their effectiveness and extend the impact they have in communities of need. Their focus on training the next generation of healers, and preserving traditional healing knowledge, also aligns with our focus on helping organisations to grow their capacity for intergenerational benefit."
RNZ News
15 hours ago
- RNZ News
Call for more medical access to commonly used illicit drugs
Prescription psilocybin, the hallucinogenic compound found in magic mushrooms, will become available to treat prescription-resistant depression. Photo: Pixabay The Drug Foundation wants more medical access to some of the most commonly used illicit drugs. It comes after the government announced prescription psilocybin , the hallucinogenic compound found in magic mushrooms, will become available to treat prescription-resistant depression. The Drug Foundation's annual report found psychedelic drug use has more than doubled in New Zealand, with 3.1 percent of adults reported taking psychedelics like LSD, psilocybin and ketamine in 2023 and 2024, compared to 1.3 percent in 2017 and 2018. It said cannabis, MDMA, and psychedelics rank down the lower end of the potential harm spectrum, and have well-documented medical uses. The Drug Foundation's executive director Sarah Helm said some people are self-medicating with such drugs, and are being criminalised by not being allowed to access them legally. "Many of our most popular illicit substances have well-documented medicinal uses and are being actively studied for their potential to treat a range of health conditions, so it's likely at least some of the use in this report is self-medication," Helm said. "We think it's time to enable more medical access to the likes of psychedelics and MDMA and stop prosecuting people who use them." In Australia, MDMA, known as ecstasy in tablet form, is being used to help treat post-traumatic stress disorder (PTSD). While earlier this year, a clinical study using mushrooms containing psilocybin to treat methamphetamine addiction completed its first phase of trials. "Criminalising anyone doesn't really help, whether the substance use is problematic or therapeutic," Helm told Morning Report. " Certainly, they [psychedelics] have been stigmatised and that's prevented access." NZ Drug Foundation executive director Sarah Helm. Photo: Supplied/ NZ Drug Foundation The release of these numbers coincides with Associate Health Minister David Seymour's announcement that psilocybin would be legally available in New Zealand outside of trials for the first time. It brings New Zealand in line with Australia, which has been using psilocybin to treat depression since 2023 . Seymour said it would initially only be available from one specific psychiatrist, but he hoped more would apply. The psychiatrist, Ōtautahi -based Dr Cameron Lacey, who was also behind the first clinical trials of psilocybin, said about two thirds of people who participated in clinical trials saw substantial improvements in their depression. "It's truly providing remarkable results and it's really exciting to see a treatment that is providing real benefit for people who typically, at that point in their treatment journey, had a really long road and low improvement from standard treatments," Dr Lacey told Morning Report. Dr Cameron Lacey. Photo: Supplied The therapy involves months of psychotherapy and one or two eight-hour psilocybin sessions or 'doses' accompanied by clinical professionals. Most of the studies have involved one or two doses integrated with a course of psychotherapy. For some, just one treatment can be sufficient . "The most important thing that we need to work on next is making sure this treatment is available to all who need it," Dr Lacy said. Helm said the announcement that the magic mushroom drug psilocybin will be available for some patients is good news, but better access is needed. "We do need to see a broader range of clinicians making it available, otherwise people do turn to self-administration. It's happens in the cannabis field, as well. It is about balancing," Helm said. Sign up for Ngā Pitopito Kōrero , a daily newsletter curated by our editors and delivered straight to your inbox every weekday.
Scoop
a day ago
- Scoop
Womb Cancer ‘Really Hitting The Pacific And Māori Communities', NZ Biologist Says
Article – RNZ Mori and Pasifika women have some of the highest rates of womb cancer in the word. , RNZ Pacific Bulletin Editor Susana Suisuiki, Pacific Waves Presenter/Producer Christina Persico, RNZ Pacific Bulletin Editor A University of Auckland biologist working on less invasive tests for womb cancer (or endometrial cancer) says studies suggest that one of its causes is higher weight or metabolic diseases, such as diabetes. The number of diagnoses of the disease in New Zealand has risen from 600 a decade ago to around 750 a year. Māori and Pasifika women have some of the highest rates of womb cancer in the world. Researchers say younger New Zealand women are now being diagnosed with womb cancer, which previously struck after menopause. It is occurring in women aged 30 to 40 and is particularly prevalent in Māori and Pasifika populations. 'We need to do a bit more work and to have a look at the numbers,' Dr Cherie Blenkiron told Pacific Waves. 'But the studies that are out there suggest that is really one of the main causes…particularly in New Zealand, for the increased number of people who are being diagnosed each year. 'Unfortunately, that really is hitting the Pacific and Māori communities.' She said there have been 'really tight studies' that have shown that one of the causes is higher weight or metabolic diseases, such as diabetes. 'What they've shown in these trials overseas is if you treat and you manage those conditions better, then you reduce the likelihood of those women developing endometrial cancer.' However, Dr Blenkiron said it is a type of cancer that can be removed if found early. Symptoms can include cramping and abnormal bleeding or spotting. 'You know your body perfectly well, so if there's any change in in bleeding, then really do get it checked out by your GP. 'Women will present with symptoms, and that really means that if they act on those symptoms…we can pick up the cancer early, we can treat it early, and this is a type of cancer that can be cured very easily with surgery or really limited forms of drugs.' The new screening tests the university is working on aim to do move away from 'quite nasty' biopsies and to minimally invasive tests, Dr Blenkiron said. 'We're looking for molecules, for example, in the blood or in little biopsies. Or one of the projects that we're doing is looking for swabs. So taking self swabs, much like have been done in cervical cancer,' she said. 'So blood tests, swab tests – much easier to take and much more painless. 'What we do with these tests is to first, hopefully, pick up the cancer earlier. So these would be screening tests. 'And second to pick the right medicine or the right treatment for each patient,' she added.
